DNA methylation matters: methylation of the γ-globin ( HBG ) gene promoters is required for postnatal silencing of HbF
Open Access
- 26 March 2026
- journal article
- Published by American Society of Hematology in Blood
- Vol. 147 (13) , 1416-1422
Abstract
Sufficient levels of fetal hemoglobin (HbF) can ameliorate the pathophysiologic basis of sickle cell disease and β-thalassemia postnatally. DNA methylation has long been posited to mediate silencing of HbF expression, but this has been controversial. Recent publications provide definitive evidence for the critical role of HBG gene promoter methylation in silencing and insight into the mechanisms involved. The data support a model in which methylation of CpG sites in the HBG promoters and repressive transcription factors recruit the MBD2-NuRD chromatin remodeling complex, which enforces silencing. These findings have implications for the treatment of β-globin disorders.Keywords
This publication has 81 references indexed in Scilit:
- Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cellsCell Chemical Biology, 2022
- Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin SwitchCell, 2018
- Developmentally‐faithful and effective human erythropoiesis in immunodeficient and Kit mutant miceAmerican Journal of Hematology, 2017
- Bcl11a Deficiency Leads to Hematopoietic Stem Cell Defects with an Aging-like PhenotypeCell Reports, 2016
- DNA methylation and the regulation of globin gene expressionCell, 1983
- Cellular differentiation, cytidine analogs and DNA methylationCell, 1980
- DNA methylation in the human γδβ-globin locus in erythroid and nonerythroid tissuesCell, 1980
- The organization of repetitive sequences in a cluster of rabbit β-like globin genesCell, 1980
- Hemoglobin switchingCell, 1978
- Use of restriction enzymes to study eukaryotic DNA methylationJournal of Molecular Biology, 1978